5 results

• Bone Matrix Tuberculosis Outbreak Leads to CDC Calls for Better Donor Screening

  January 9, 2024

  Katherine McDaniel

  The CDC is calling for increased screening of bone donor patients following at least two tuberculosis outbreaks linked to infected bone donated in recent years.

• Bone Matrix Graft Products Linked to Tuberculosis Risks, FDA Warns

  September 13, 2023

  Irvin Jackson

  The FDA warns that bone matrix graft products appear to be prone to tuberculosis outbreaks, and calls for more stringent screening of donors.

• FDA Issues Letter To Doctors About Issues with NuVasive Precice Limb-Lengthening Devices

  June 29, 2023

  Martha Garcia

  The FDA is updating warnings about problems with NuVasive Precice limb-lengthening implants following past concerns over biocompatibility.

• Mechanical Failures, Biocompatibility Problems with NuVasive MAGEC System Implants Lead To FDA Warning

  July 19, 2021

  Russell Maas

  The FDA is warning of more biocompatibility concerns with NuVasive bone implants, indicating the MAGEC system used in children may cause adverse reactions and could suffer mechanical failure.

• FDA Warns of Biocompatibility Risks With NuVasive Specialized Orthopedics’ Precice devices

  July 12, 2021

  Russell Maas

  The FDA is warning of potential adverse reactions linked to NuVasive Precice bone implants, which may be caused by the metals being used.